Naproxen Sodium Tablet, Film Coated
Product Images NDC 11822-4171

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Naproxen Sodium (NDC 11822-4171). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rite Aid Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rite Aid 44-417 (Rite Aid 44 417 1)

This is a drug facts sheet for Naproxen Tablets. It is a pain reliever and fever reducer. It is important to consult a healthcare professional before use, particularly for pregnant or breastfeeding women. The tablet should be taken as directed, not exceeding 3 tablets in a 24-hour period. If symptoms persist or worsen, stop use and ask a doctor. There are warnings regarding stomach bleeding and heart attack/stroke risks associated with this product, particularly for people over age 60 or who have had stomach ulcers or bleeding problems. Anyone with a history of serious health conditions or taking other medications should consult a doctor or pharmacist before use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.